Did Thomas Rooney buy Core Laboratories stock?

Common questions

Did Thomas Rooney buy Core Laboratories stock?

Yes. Thomas Rooney disclosed 1 purchase and 2 sales of Core Laboratories (CLB) stock between Dec 8, 2017 and Dec 10, 2018, in STOCK Act reports. Added together, the disclosed purchases come to $15K-$50K and the disclosed sales to $30K-$100K.

How big were Thomas Rooney's Core Laboratories trades?

STOCK Act reports give a range for each trade, such as $15K-$50K, never an exact amount. Added together, the disclosed purchases come to $15K-$50K and the disclosed sales to $30K-$100K.

Did Thomas Rooney make these Core Laboratories trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Thomas Rooney still own Core Laboratories stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Thomas Rooney report these trades?

The latest filing is dated Jan 14, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.